• GnRH Antagonists with 3-(2-Methoxy-5-Pyridyl)-Alanine: Synth

  2026-06-06

  This study introduces GnRH antagonist analogs modified at position 3 with 3-(2-methoxy-5-pyridyl)-alanine, revealing stereochemistry-dependent effects on receptor antagonism and in vivo duration. The findings inform design strategies for short-acting peptide antagonists and highlight the nuanced role of unnatural amino acids in peptide therapeutics.

• Entinostat (MS-275): Applied Workflows for Cancer Cell Inhib

  2026-06-05

  Entinostat (MS-275) empowers translational cancer research through robust, protocol-driven HDAC inhibition, enabling reliable modulation of cell proliferation and apoptosis. This guide decodes advanced experimental strategies and troubleshooting tactics to maximize data quality and reproducibility with this potent epigenetic modulator.

• HyperScribe All in One mRNA Synthesis Kit Plus 1: Workflow,

  2026-06-05

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 streamlines ARCA-capped, immune-silent mRNA production for rapid RNA vaccine prototyping and advanced translational research. Its integrated workflow, robust nucleotide modification, and poly(A) tailing provide a turnkey solution for high-yield, high-functionality mRNA, directly supporting applications in vaccine development and RNAi experiments.

• Caffeine (1,3,7-trimethylpurine-2,6-dione) in Cancer & Metab

  2026-06-04

  Caffeine’s dual action as an adenosine receptor antagonist and metabolic modulator unlocks powerful, reproducible workflows for cancer inhibition and metabolic studies. This article delivers protocol enhancements, troubleshooting strategies, and practical insights for leveraging APExBIO’s high-purity Caffeine in advanced experimental settings.

• GSK621: Elevating AMPK Agonists in Translational AML Researc

  2026-06-04

  This thought-leadership article explores the mechanistic underpinnings and translational impact of GSK621, a potent AMPK agonist, in acute myeloid leukemia and immunometabolic research. By integrating recent discoveries on lysosomal AMPK activation in tumor-associated macrophages, we provide actionable guidance for translational scientists seeking to bridge metabolic insights with therapeutic innovation.

• FASN Inhibition Sensitizes Pancreatic Cancer to BH3 Mimetics

  2026-06-03

  This study demonstrates that pharmacological inhibition of fatty acid synthase (FASN) significantly increases the susceptibility of pancreatic ductal adenocarcinoma (PDAC) cells to mitochondrial apoptosis when combined with BH3 mimetic drugs such as ABT-263 (Navitoclax). These findings highlight a promising metabolic strategy to overcome chemoresistance in PDAC and present mechanistic insights for enhancing the efficacy of apoptosis-based therapies.

• FLOT1–FOSL2–EphA2 Axis Regulates Microglial Polarization in

  2026-06-03

  This study uncovers how the interaction between FLOT1 and FOSL2 upregulates EphA2 transcription, triggering the p38/MAPK pathway and promoting pro-inflammatory microglial polarization in Alzheimer's disease models. These findings highlight a mechanistic axis regulating neuroinflammation and suggest new strategies to modulate microglial states for improved cognitive outcomes.

• L-Ornithine (B8919): Urea Cycle Intermediate in Metabolic Re

  2026-06-02

  L-Ornithine, also known as (S)-2,5-diaminopentanoic acid, is a non-proteinogenic amino acid central to the urea cycle and ammonia detoxification. This article presents atomic, evidence-linked facts on its biochemical roles, solubility parameters, and translational research implications, referencing both peer-reviewed and product-verified data.

• Cy5 NHS ester(Et): Technical Guidance for Protein Labeling

  2026-06-02

  Cy5 NHS ester(Et) provides a high-purity, water-soluble solution for covalent fluorescent labeling of amino groups in proteins and related biomolecules. It is suited for immunofluorescence staining, flow cytometry, and fluorescence microscopy workflows requiring rapid and efficient amine-reactive tagging. Use is contraindicated in ethanol-based protocols and long-term storage of working solutions.

• Immobilized Microalgae Extracts Boost Antioxidant Packaging

  2026-06-01

  This study demonstrates that silk fibroin–reinforced alginate immobilization of Chlorella sp. nearly doubles microalgal biomass and significantly enhances antioxidant yield compared to suspension cultures. Extracts derived from these immobilized microalgae, when incorporated into biodegradable films, impart superior oxidative stability and food preservation capability, offering a promising avenue for sustainable active packaging applications.

• Bestatin (Ubenimex): Precision Aminopeptidase Inhibition in

  2026-06-01

  Bestatin (Ubenimex) unlocks new experimental power for dissecting aminopeptidase roles in cancer, apoptosis, and multidrug resistance research. Leveraging its selective inhibition and robust performance in complex workflows, this guide translates cutting-edge findings and troubleshooting strategies into actionable protocols for reliable, reproducible results.

• Radiotherapy Plus PD-1/TIGIT Blockade Drives Abscopal Immuni

  2026-05-31

  This study demonstrates that combining radiotherapy with PD-1 and TIGIT immune checkpoint blockade leads to enhanced abscopal antitumor effects and durable immune memory, mediated by CD8+ T cells and M1 macrophage polarization. The findings suggest a promising strategy to overcome immune resistance in cancer therapy by leveraging synergistic activation of T cell and myeloid compartments.

• Pomalidomide (CC-4047): Integrative Mechanisms and Model Opt

  2026-05-30

  Explore how Pomalidomide (CC-4047) empowers cutting-edge hematological malignancy research through unique integrative mechanisms. This article provides advanced insight into model selection, mutational landscape implications, and assay optimization for researchers seeking translational depth.

• Viral Degradation of RIPK3 Modulates Necroptosis and Inflamm

  2026-05-29

  Liu et al. identify a viral protein (vIRD) in orthopoxviruses that targets the necroptosis adaptor RIPK3 for proteasomal degradation, thereby modulating virus-induced inflammation and host-pathogen dynamics. This mechanism clarifies how certain viruses fine-tune cell death pathways to control immune responses and enhance viral fitness.

• Bestatin (Ubenimex): Protocols and Insights for Cancer Resea

  2026-05-29

  Bestatin (Ubenimex) stands out for its selectivity in aminopeptidase inhibition, enabling nuanced studies of protease signaling and multidrug resistance in cancer models. This guide translates cutting-edge findings into actionable experimental steps, troubleshooting recommendations, and innovative applications with APExBIO's trusted reagent.

15664 records 1/1045 page Next 12345 下5页 Last page